2022 Impact Report

The 31st annual Irwin M. Arias Symposium, Bridging Basic Science and Liver Disease was held on November 10th. This one-day virtual event attracted over 500 leading biomedical scientists and physicians from across the globe. Designed to bridge the remarkable advances in basic biology and engineering with the understanding of liver diseases and their treatments, this event is one that basic, translational and physician scientists look forward to every year. IRWIN M. ARIAS SYMPOSIUM

David E. Cohen, MD, PhD, Professor of Medicine and Chief of Gastroenterology, Hepatology & Endoscopy at Brigham and Women's Hospital was ALF’s 2022 Distinguished Scientific Achievement Awardee. Dr. Cohen was recognized for his extensive research on the pathogenesis of nonalcoholic fatty liver disease, which is now being used to develop new treatments for nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) and other liver disorders. DISTINGUISHED SCIENTIFIC ACHIEVEMENT AWARD

The last few years have been tough on all of us, especially medical professionals experiencing burnout. For Mental Health Awareness Month in May, ALF held a webinar with Claudine Holt, MD, MPH, Occupational Medicine Physician and Certified Life & Embodiment Coach at Mount Sinai Hospital in New York City, focused on ways to prioritize mental health and recover from burnout. LIFE BEYOND BURNOUT MOCK LIVER CANCER TUMOR BOARDS Over 40 medical professionals joined our East and West Coast Mock Liver Cancer Tumor Boards. Both programs reviewed patient selection, surgical techniques, prognosis, and more to educate a variety of medical providers about the latest innovations in liver resection and tumor removal.

Made with FlippingBook - Online catalogs